ARHGAP30 and familial pancreatic carcinoma: These results indicate that ARHGAP30 overexpression may ameliorate pancreatic cancer progression by inhibiting proliferation and metastasis and promoting apoptosis via regulation of the β-catenin pathway and related genes.